Infinium Global Research has added
a new report on Orphan Drugs
Market. The report presents analysis of
global as well as regional markets of orphan drugs market over the period of
2016 to 2024. These drugs are used to treat the population suffering from the
very serious, but rare diseases for which no treatment available. There are
around 25 to 30 million people are affected by this diseases in Europe. The
awareness about the orphan drug is growing rapidly across the world that
further leads to the growing adoption of orphan drug act in the japan,
Australia, Europe and others countries to stimulate research and development in
the orphan drug. The orphan drug market segmented as diseases indication,
product type, and distribution channels. The segment dieses type is further
divided into sub segment including Oncology, Gastrointestinal, Pulmonary,
Neurology, Hematology, Cardiovascular, Metabolic disorders, Endocrinology,
Infectious diseases and other. The product type segment included Biological and
Non-bio logical products and distributed over the channels like hospital
pharmacy, retail pharmacy and others.
Economic incentives to encourage
drug companies to develop and market medicines for rare disease treatment is
the key driving factor in the orphan drug market. The rising occurrence of rare
cancer cases, availability of orphan drugs at hospital pharmacy and increasing
hospitalization treatment for rare diseases are expected to enhance the growth
of orphan drug market over the forecast period. On the other hand, the cost
associate with production and R&D is more as compare with other drugs that
may hampering the market growth. Moreover, the rising awareness of rare disease
among population and increasing investments in R&D is projected to create
several opportunities in upcoming years. Moreover, the growth matrix presented
by Infinium Global Research identifies the key investment markets in the near
future, this will not only help the companies to understand the competitive
position in the global orphan drugs market but also make strategic decisions to
capture the most lucrative markets in the near future. The market size is
presented in terms of value for the historic year 2016 and estimated for
forecast period of 2018-2024.
Get
15% discount for early purchase of global orphan drugs market report by
clicking the following link, Use code IGRD15 to request the discount in the
given form
https://www.infiniumglobalresearch.com/reports/request-discount/1619
The recent report identified that North
America dominated the global orphan drugs market over the last couple of years,
while emerging markets of Asia-Pacific and Latin America are anticipated to
contribute significantly to the growth in the orphan drugs market worldwide.
The report segments the global
orphan drugs market on the basis of Disease Type, Product Types and
Distribution Channel.
Global Orphan Drugs Market by
Disease Type
·
Oncology
·
Gastrointestinal
·
Pulmonary
·
Hematology
·
Neurology
·
Infectious Diseases
·
Others
Global Orphan Drugs Market by
Product Types
·
Biologic
·
Non-biologic
Global Orphan Drugs Market by
Distribution Channel
·
Hospital Pharmacies
·
Specialty Pharmacies
·
Retail Pharmacies
Companies Profiled in the Report
·
Novartis AG
·
Pfizer Inc.
·
Alexion Pharmaceuticals
·
Eisai Co. Ltd.
·
Bayer AG
·
Biogen Inc
·
Eli Lilly and Company
·
AstraZeneca plc.
·
GlaxoSmithKline
·
Johnson & Johnson
About Infinium Global Research
Infinium Global Research is a
business intelligence company that provides its clients with market information
services, solutions, and reports. The intelligence reports include qualitative
as well as quantitative information, which are blended using forecasting models
in order to project future market demand. Our panels of Subject Matter Experts
(SMEs), Analysts, and Consultants use numerous data gathering tools in order to
provide you with detailed information on the market as well as a preview of its
projected growth. Our repository includes the largest and most credible
databases, through which we determine various qualitative and quantitative
parameters of the market to provide you with an in-depth business intelligence
report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.
